Top compounds associated with response to TCTA


Feature Type Standardized
Nominal ANOVA
mRNA KIN001-266 GDSC1000 pan-cancer AAC 0.019 0.6
mRNA YM-155 CTRPv2 pan-cancer AAC -0.022 0.6
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.019 0.6
mRNA AMG-706 FIMM pan-cancer AAC -0.092 0.6
mRNA marinopyrrole A CTRPv2 pan-cancer AAC -0.027 0.6
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.021 0.6
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.019 0.6
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.027 0.6
mRNA SB590885 GDSC1000 pan-cancer AAC -0.018 0.6
Download CSV